February 14, 2025 2024 Year In Review by Dr. Laia Montoliu-Gaya: Key Findings in Blood Based Biomarkers for Alzheimer’s Disease read more
December 2, 2024 CTAD 2024 Fuels the Momentum in Advancing Alzheimer’s Disease Detection & Treatment with a Spotlight on Blood-Based Biomarkers read more
March 29, 2024 Breaking Ground in Alzheimer’s Diagnosis: Simoa® p-Tau 217 Blood Test Receives FDA Breakthrough Device Designation read more
February 13, 2024 CSF p-Tau 205 Emerges as a Biomarker of Tau Pathology in Alzheimer’s Disease read more
November 16, 2023 Utilizing Digital ELISA for Precise Measurement of Brain Biomarkers in Blood read more
November 7, 2023 Publication Review: Unraveling the Role of Plasma GFAP in Parkinson’s Disease read more